Working… Menu

Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients (LUPSA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04291300
Recruitment Status : Recruiting
First Posted : March 2, 2020
Last Update Posted : May 28, 2020
Dutch Cancer Society
Information provided by (Responsible Party):
Radboud University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 26, 2022
Estimated Study Completion Date : May 1, 2024